Načítá se...
Interim treatment: Bridging delays to opioid treatment access
OBJECTIVE: Despite the undisputed effectiveness of agonist maintenance for opioid dependence, individuals can remain on waitlists for months, during which they are at significant risk for morbidity and mortality. To mitigate these risks, the Food and Drug Administration in 1993 approved interim trea...
Uloženo v:
| Vydáno v: | Prev Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592374/ https://ncbi.nlm.nih.gov/pubmed/25937593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ypmed.2015.04.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|